# Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

> **NCT05549232** · — · COMPLETED · sponsor: **Hemanext** · enrollment: 22 (actual)

## Conditions studied

- Hematologic Neoplasms
- Burns

## Interventions

- **DEVICE:** Hypoxic Red Blood Cells

## Key facts

- **NCT ID:** NCT05549232
- **Lead sponsor:** Hemanext
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-24
- **Primary completion:** 2024-05-16
- **Final completion:** 2024-05-16
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05549232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05549232, "Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05549232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*